This Article  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

edited by R. F. Prien and D. S. Robinson, 752 pp, $85, New York, NY, Raven Press, 1994.

Irene Hegeman Richard, MD, Reviewer
Rochester, NY

Arch Neurol. 1996;53(2):119.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

This text is a source book in clinical trials of psychotropic drugs that incorporates the experience of a wide group of experts. A joint American College of Neuropsychopharmacology and National Institute of Mental Health task force was established to develop this extremely thorough work. The natural flow of chapters, despite numerous authors, reflects the careful planning in creating this book. There are numerous recent references, and the index is easy to use.

The text opens with an interesting section on historical perspectives and becomes gradually more specific. Section II walks the reader logically through general principles in the evaluation of psychotropic drugs. This comprehensive and well-organized section begins with design issues; continues on to patient selection, assessment of clinical change, pharmacologic considerations, statistical issues, clinical trial implementation, premarketing safety, postmarketing surveillance, and documenting and reporting study results; and concludes with an important chapter on ethical and legal considerations. Although references . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?